SThree Annual Results and Report Released

Gary continues, "Our strategic approach of diversifying by region and sector, with a key focus on growing our Contract business, has added resilience to our earnings, enabling us to weather the political and economic uncertainties that we have faced through 2016."

Our business mix continued to shift in favour of Contract, a business where we continue to see attractive growth opportunities and one which is also more resilient in times of uncertainty.

Contract and Permanent

We have now achieved a 67% split in favour of Contract, a growth of 3% YoY. The Permanent side of our business now represents 33% of Group GP, in line with our stated strategy of retaining a well-diversified business. We believe that this balance towards Contract continues to represent the best long-term approach for the company and, during 2017, we expect that Contract will continue to grow as a percentage of total Group GP, while we also maintain our sharp focus on improving yields and selectively growing headcount in Permanent.

At a regional level, the Group continues to become ever more international, with 75% of Group GP now derived from markets outside its historic base in the UK. Our strongest performances included Continental Europe (up 13%*), where very strong client and candidate delivery by our teams ensured we capitalised on a buoyant market.

During 2016 we expanded our US footprint by opening offices in Austin and Minneapolis as well as by launching Madison Black, a specialist digital marketing brand, in New York.

We have also laid the foundations for further growth within our existing regions by adding office capacity in some key locations and preparing for additional moves and new office openings in 2017. At the same time we continue to manage costs and contractual commitments carefully.

Looking ahead

Gary says, "Looking ahead, the heightened level of political and economic uncertainty remains the primary feature of our trading outlook. Against this backdrop we will continue to focus on the Contract market, where we see attractive growth opportunities and which is more resilient in periods of economic uncertainty. As we have done in 2016, we will pay close attention to productivity and underlying costs."

"We have shown in previous periods of uncertainty that we can optimise our performance. We will retain a prudent approach to planning and selective investment in growth, while preserving the agility to respond quickly to market opportunities as they arise, in the year ahead," says Gary.

To view the SThree Annual Report and read the full year results announcement, visit the SThree investor’s page here.

IR35: Why it’s important for our PSC contractors to hold business insurance

17 Feb 2020

It’s important that you, as a PSC contractor, are doing all you can to make sure you’re on the right side of IR35

Tags: IR35
Forscherin im Labor

Where is Singapore in its digital pharma journey?

11 Oct 2019

As the region’s technological hub, Singapore’s digital journey has rapidly evolved with sophisticated technologies and innovation. As such, the nation is well-poised to transform the future of pharma within Southeast Asia. But what exactly is the impact of digital disruption in the sector, what does it mean and how is it going to impact the pharmaceutical scene?

Capital Investment in Healthcare

19 Sep 2019

The government announces 20 new capital investment projects worth a total of £853m designed to show its commitment to increasing NHS funding.

SThree publishes Annual Report

03 Mar 2020

The report shows that the company’s unique position as the only pure-play, global STEM staffing specialist.